Clinical Trial Update: A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE) [Phase 3]

View source ↗

Summary

Phase 3 trial update for dalcetrapib in patients hospitalized with acute coronary syndrome has completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Coronary Syndrome

Drugs mentioned

• Dalcetrapib (dalcetrapib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Coronary Heart Disease | Phase 3 | Status: COMPLETED | Results posted: 2018-08-06